Spinal Muscular Atrophy (SMA) Symptoms: Signs by Type

Spinal Muscular Atrophy (SMA) Symptoms: Signs by Type

A baby with trouble breathing, a weak cry with poor feeding, or blue or grey lips needs emergency care now. Call 911 or go to the emergency department.

This page explains what those signs can look like at different ages, which tests a clinician may order, and what a result can and cannot tell a family. It is educational and not medical advice.

What can cause weak muscles, floppiness or missed milestones?

Weak or floppy muscles and slow motor progress in a baby have a long list of possible explanations, and SMA is one of them. Without ranking them, the possibilities a pediatrician works through include prematurity and early birth, recovery from a recent illness, feeding difficulty and low intake, thyroid and metabolic conditions, injury to the brain or spinal cord around birth, other nerve and muscle conditions, and genetic conditions including SMA. Normal variation in when babies reach a given milestone also exists.

Several of these possibilities are sorted out by the story the family tells and by a hands-on examination rather than by a blood test. The pediatrician looks at muscle tone, head control, reflexes, how a baby feeds, how the chest moves during breathing, and whether a skill that was present earlier has changed.

In an older child or an adult, new weakness around the hips and shoulders can come from deconditioning, poor sleep, low food intake, thyroid and metabolic conditions, and nerve or muscle conditions. Later onset forms of SMA also exist, so a clinician considers them alongside everything else. None of this is something to work out alone. A clinician decides what the picture reflects.

What are the symptoms of SMA?

The symptoms of SMA come from weakness of the muscles closest to the trunk and of the muscles used for breathing, coughing, swallowing and speech, so the signs cluster around movement, feeding and breathing 1. What a family notices depends on the age at which signs begin.

Signs described in children include the following.

In later onset forms, the first thing noticed can be difficulty climbing stairs, difficulty rising from the floor or a chair, a waddling walk, or falls 1. Weakness in SMA is described as affecting both sides and the muscles closest to the trunk more than the hands and feet 3.

None of these signs on their own points to one condition. They are reasons to book an assessment with the child's pediatrician, who decides what testing is appropriate.

How do SMA types differ by age of onset?

SMA is grouped into types by the age at which signs begin and by the highest motor function reached, which is why two people described as having SMA can look very different 3.

Type When signs can begin What is described
Type 1 Early infancy Marked weakness and low tone, head control not achieved, feeding and breathing muscles involved 1
Type 2 Later infancy and early childhood Sitting achieved while standing and walking are not, with spinal curvature and breathing muscle weakness described 4
Type 3 After walking has been achieved Weakness around the hips and legs, falls, difficulty with stairs and with rising from the floor 3

Research suggests that respiratory, swallowing, feeding and speech functions follow different patterns across the SMA types, which is why care plans are built around the individual rather than the label 2. A review of the clinical features of SMA type 2 describes children who achieve sitting, alongside spinal curvature and weakness of the muscles used for breathing as part of the picture 4.

Type numbers are a shorthand used by clinicians. The neurologist and pediatrician describe what a particular child can do and what support that calls for.

Which tests can help explain these signs?

No routine blood count or chemistry panel answers this question. The test that looks directly at SMA is a molecular genetic test of the SMN1 gene, arranged by a clinician 5.

Marker or test Why it is linked to these signs What a result can and cannot tell you
SMN1 gene test SMN1 carries the instructions for the SMN protein that motor nerve cells depend on, and molecular testing looks at this gene 5 Reported as the laboratory prints it. A specialist interprets the finding together with the examination, and decides whether further genetic testing is needed
SMN2 copy number SMN2 is a near copy of SMN1 and the number of copies is reported alongside the SMN1 result in genetic counseling for SMA 5 A number that a specialist uses in discussion with the family. It does not stand alone and does not describe one child's course
Carrier testing for parents SMA linked to chromosome 5q is inherited in a recessive pattern, and carrier frequency has been reviewed across populations 6 Interpreted by a genetic counselor for the family as a whole. A carrier result is about inheritance, not about the person's current health
Neurofilament light protein This protein is released when nerve cells are injured, and it has been reviewed as a biomarker in SMA with age related reference ranges 7 Used in specialist settings. It is not a general screening test and it does not single out one condition
Creatine kinase A blood marker of muscle breakdown that a clinician may order while working through causes of weakness Read as printed on the lab report. A value outside the printed range is worth discussing with a clinician, who decides what it reflects
Nerve conduction tests and EMG Tests of how nerves and muscles carry and respond to electrical signals, ordered by a neurologist They describe how nerves and muscles are behaving. A genetic test is what looks at the SMN1 gene 5

Reference ranges vary by laboratory, age and sex. For a child, results are read as printed on the lab report and discussed with the child's pediatrician, because ranges built for adults do not apply.

Can a blood test look at the SMN1 gene?

Yes. Molecular genetic testing on a blood sample is how the SMN1 gene is examined, and it is the route described for confirming SMA linked to chromosome 5q 5.

The mechanism behind the signs is straightforward to describe. Motor nerve cells in the spinal cord need the SMN protein, SMN1 is the gene that supplies it, and when that supply is reduced those nerve cells struggle to drive the muscles they serve 5.

A few things change what this test can settle. Forms of SMA that are not linked to chromosome 5q exist and have their own genetic profiles, so a negative SMN1 result does not end the assessment and wider genetic testing may follow 3. Testing methods also differ in what they detect, and a geneticist decides which approach fits the question being asked 5.

What does SMN2 copy number add?

SMN2 copy number is a second number reported alongside the SMN1 result, and it is part of genetic counseling conversations in SMA 5. SMN2 is a near copy of SMN1 that makes a smaller amount of working SMN protein.

Research suggests that SMN2 copy number acts as a modifier of how SMA presents, which is one reason it is reported 5. It is a group level pattern rather than a statement about one child, and a neurologist reads it together with what the child can do on examination.

What else changes the number on the page is the laboratory method used to count copies. A result is read as printed on the report and discussed with the specialist who ordered it.

How does newborn screening for SMA work?

Which conditions are on a panel differs between programs, so the hospital or pediatrician is the place to ask what a particular program covers.

A screening test is designed to flag babies who need a closer look, not to settle the question. Confirmatory genetic testing and a specialist assessment follow, and the specialist team decides what happens next. A screen that did not flag anything does not rule out every cause of weakness, so new signs are still worth raising with the child's pediatrician.

Who can be a carrier of an SMN1 change?

A carrier is someone who has one altered copy of SMN1 and one working copy, which matters for family planning rather than for that person's own muscle strength. SMA linked to chromosome 5q is inherited in a recessive pattern, and its prevalence, incidence and carrier frequency have been reviewed across populations 6.

Carrier testing and genetic counseling are described as part of the molecular approach to SMA, and a genetic counselor explains what a carrier result means for parents, siblings and future pregnancies 5. Carrier testing has limits that a counselor will set out, including the fact that no test detects every possible change in a gene 5.

This is a conversation to have with a genetics service, not a result to interpret from a printout at home.

Can neurofilament light protein be measured in SMA?

Neurofilament light protein is released into blood and spinal fluid when nerve cells are injured, and it has been reviewed as a biomarker in SMA together with reference ranges 7.

Evidence suggests that neurofilament light protein levels differ by age, which is why age specific reference ranges are reported for it rather than a single number for everyone 7. That matters for interpretation. A value sitting outside the range printed for a child's age group is worth discussing with the specialist team, who decide what it reflects in context.

Neurofilament light protein is not a general screening test and it does not single out one condition. It reflects nerve cell injury from any cause, so it is read alongside the examination, the genetic result and the rest of the picture.

How are breathing, sleep and feeding looked after?

Published recommendations for SMA cover rehabilitation, orthopedic care such as spinal curvature, and nutritional care as standing parts of follow up 1.

Sleep related breathing problems are associated with weakness of the respiratory muscles in children with SMA, and sleep tests together with non-invasive breathing support are described as part of respiratory care 8. Breathing can change during sleep before it changes during the day, which is why a respiratory team may suggest overnight monitoring 8.

On the feeding side, a natural history review describes swallowing, feeding and speech functions as affected in SMA, which is why speech and language therapists and dietitians are part of the team 2.

Every one of these decisions belongs to the child's pediatrician and the specialist team. If medicines come up at any point, ask your prescriber, and treatment decisions belong to a licensed provider.

What can a normal panel still miss?

A reassuring looking panel is not a reason to stop asking about weakness or a lost skill.

Other things no blood test captures include the following.

Testing answers the questions it was designed to answer. The examination and the history carry the rest.

For related topics, see muscle weakness causes, scoliosis causes and trouble swallowing.

When should you get medical help quickly?

Some signs need emergency care and no delay. Call 911 or go to the emergency department for any of the following.

Other signs are reasons to arrange a prompt assessment with your own or your child's clinician rather than to wait and see.

No one should be working through this alone or from a search result. Bring what you have noticed, including video of the movement that worries you, to your clinician, and discuss any test result or treatment question with a clinician or licensed provider before acting on it.

If you are having thoughts of self-harm, call or text 988 (US) or your local emergency number now.

How can you check markers like these?

If the concern is about a baby or child, the first step is an appointment with the child's pediatrician, who examines the child and decides which tests fit.

For adults who want their routine blood markers measured and explained, the FitScript Essential panel covers standard blood markers that a clinician may use when sorting through fatigue, weakness or low energy. FitScript tests 150+ biomarkers per year, and Atlas, the AI health advisor, explains what each result means in plain language. A licensed clinician reviews the picture and decides on any next step.

Key takeaways

References

  1. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscular disorders : NMD, 2018.
  2. A Systematic Literature Review of the Natural History of Respiratory, Swallowing, Feeding, and Speech Functions in Spinal Muscular Atrophy (SMA). Journal of neuromuscular diseases, 2024.
  3. Clinical and Genetic Profiles of 5q- and Non-5q-Spinal Muscular Atrophy Diseases in Pediatric Patients. Genes, 2024.
  4. Clinical features of spinal muscular atrophy (SMA) type 2. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2020.
  5. Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA). Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2020.
  6. Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. Orphanet journal of rare diseases, 2017.
  7. Neurofilament light protein as a biomarker for spinal muscular atrophy: a review and reference ranges. Clinical chemistry and laboratory medicine, 2024.
  8. The role of sleep diagnostics and non-invasive ventilation in children with spinal muscular atrophy. Paediatric respiratory reviews, 2018.

Common questions

What are the symptoms of spinal muscular atrophy?

Spinal muscular atrophy affects the motor nerve cells that drive movement, so the signs centre on muscle weakness. In babies this can look like floppy low tone muscles, head lag, a weak cry or cough, trouble feeding, and motor milestones that are late, missed or lost. A pediatrician and a neurologist assess any of these.

At what age do SMA signs first appear?

It varies, which is why SMA is grouped into types by age of onset. Signs can begin before or around birth, in infancy, in early childhood after a child has started walking, or in adult life. The age at which signs begin and what a person can do are both part of how a specialist describes it.

How is SMA tested for?

Through a molecular genetic test on a blood sample that looks at the SMN1 gene, ordered by a clinician. A neurologist may also arrange nerve conduction tests or muscle testing while working through causes of weakness. Where a newborn screening program includes SMA, the bloodspot sample taken after birth is tested first and any positive screen leads to confirmatory testing.

Does a regular blood panel pick up SMA?

No. A blood count, a chemistry panel and thyroid markers do not look at the SMN1 gene, so they can all sit inside the ranges printed on the report. If weakness, feeding difficulty or a lost skill is the concern, raise it with a clinician regardless of what a routine panel says.

What does it mean to be an SMA carrier?

A carrier has one altered copy of the SMN1 gene and one working copy. The result matters mainly for family planning and for other relatives, and a genetic counselor explains what it means for parents, siblings and future pregnancies. Carrier testing has limits, and the counselor will set those out before and after testing.

Can SMA signs start in adulthood?

Yes. Adult onset forms are described, with weakness in the muscles closest to the trunk such as the hips and shoulders. New difficulty climbing stairs, rising from a chair, muscle cramps or falls are reasons to arrange a prompt assessment with a clinician, who decides which tests fit the picture.

What should I do if my baby has trouble breathing or will not feed?

Call 911 or go to the emergency department. Trouble breathing, blue or grey lips or skin, a baby who will not feed at all, a baby who is very hard to wake, no wet diaper for 6 hours, or fever in a newborn or very young infant are all emergency signs. Do not wait for an appointment.

Which clinicians look after a child with SMA?

The child's pediatrician leads and coordinates care, with a neurologist involved in assessment and follow up. Depending on what the child needs, the team can include a respiratory specialist, a physiotherapist, an occupational therapist, a speech and language therapist, a dietitian and an orthopedic specialist. Every treatment decision belongs to a licensed provider.

Related reading